Cargando…
Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?
Orphan drugs (ODs) are intended for the diagnosis, prevention, or treatment of rare diseases. Many cancer subtypes, including all childhood cancers, are defined as rare diseases, and over one-third of ODs are now intended to treat oncology indications. However, market access for oncology ODs is beco...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473500/ https://www.ncbi.nlm.nih.gov/pubmed/28652787 http://dx.doi.org/10.2147/CEOR.S134230 |